AU635062B2 - Escherichia coli vaccine - Google Patents

Escherichia coli vaccine Download PDF

Info

Publication number
AU635062B2
AU635062B2 AU61099/90A AU6109990A AU635062B2 AU 635062 B2 AU635062 B2 AU 635062B2 AU 61099/90 A AU61099/90 A AU 61099/90A AU 6109990 A AU6109990 A AU 6109990A AU 635062 B2 AU635062 B2 AU 635062B2
Authority
AU
Australia
Prior art keywords
toxin
coli
vaccine
strains
flagella
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU61099/90A
Other languages
English (en)
Other versions
AU6109990A (en
Inventor
Johannes Franciscus Van Den Bosch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervet International BV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo NV filed Critical Akzo NV
Publication of AU6109990A publication Critical patent/AU6109990A/en
Application granted granted Critical
Publication of AU635062B2 publication Critical patent/AU635062B2/en
Assigned to INTERVET INTERNATIONAL B.V. reassignment INTERVET INTERNATIONAL B.V. Alteration of Name(s) in Register under S187 Assignors: AKZO N.V.
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU61099/90A 1989-08-18 1990-08-17 Escherichia coli vaccine Expired AU635062B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP89202110 1989-08-18
NL89202110 1989-08-18

Publications (2)

Publication Number Publication Date
AU6109990A AU6109990A (en) 1991-02-21
AU635062B2 true AU635062B2 (en) 1993-03-11

Family

ID=8202455

Family Applications (1)

Application Number Title Priority Date Filing Date
AU61099/90A Expired AU635062B2 (en) 1989-08-18 1990-08-17 Escherichia coli vaccine

Country Status (16)

Country Link
US (1) US5750115A (OSRAM)
EP (1) EP0413378B1 (OSRAM)
JP (1) JP3031561B2 (OSRAM)
KR (1) KR0177510B1 (OSRAM)
CN (1) CN1062605C (OSRAM)
AU (1) AU635062B2 (OSRAM)
CA (1) CA2022420C (OSRAM)
DE (1) DE69016129T2 (OSRAM)
DK (1) DK0413378T3 (OSRAM)
ES (1) ES2070266T3 (OSRAM)
GR (1) GR3015782T3 (OSRAM)
HU (2) HU210965B (OSRAM)
IL (1) IL95175A (OSRAM)
NZ (1) NZ234933A (OSRAM)
TW (1) TW204353B (OSRAM)
ZA (1) ZA906100B (OSRAM)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2042718T3 (es) * 1987-10-26 1993-12-16 Akzo Nv Procedimiento para la preparacion de una vacuna para proteger aves de corral contra septicemia producida por e. coli.
US6749831B1 (en) * 1997-05-16 2004-06-15 Medical Defense Technology, Llc Vaccine against lipopolysaccharide core
JP2001527562A (ja) * 1997-05-16 2001-12-25 メディカル ディフェンス テクノロジーズ エルエルシー リポ多糖コアに対するワクチン
IL139538A0 (en) * 1998-05-15 2004-02-08 Mkb Invest Ltd Partnership Compositions and method for immunizing poultry
US8828226B2 (en) 2003-03-01 2014-09-09 The Trustees Of Boston University System for assessing the efficacy of stored red blood cells using microvascular networks
EP1934349A4 (en) * 2005-08-30 2009-05-27 Commw Scient Ind Res Org BACTERIAL INTRODUCTION OF BIOLOGICALLY ACTIVE POLYPEPTIDES
US12089589B2 (en) 2009-10-12 2024-09-17 Hemanext Inc. Irradiation of red blood cells and anaerobic storage
US11284616B2 (en) 2010-05-05 2022-03-29 Hemanext Inc. Irradiation of red blood cells and anaerobic storage
CN102905522A (zh) 2009-10-12 2013-01-30 新健康科学股份有限公司 用于从红细胞中除去氧的氧消耗装置和方法
US9199016B2 (en) 2009-10-12 2015-12-01 New Health Sciences, Inc. System for extended storage of red blood cells and methods of use
NZ599891A (en) 2009-10-12 2014-06-27 New Health Sciences Inc Blood storage bag system and depletion devices with oxygen and carbon dioxide depletion capabilities
WO2012027582A1 (en) 2010-08-25 2012-03-01 New Health Sciences Method for enhancing red blood cell quality and survival during storage
ES2957338T3 (es) 2010-11-05 2024-01-17 Hemanext Inc Irradiación de glóbulos rojos y almacenamiento anaeróbico
US9067004B2 (en) 2011-03-28 2015-06-30 New Health Sciences, Inc. Method and system for removing oxygen and carbon dioxide during red cell blood processing using an inert carrier gas and manifold assembly
US8926980B2 (en) * 2011-07-11 2015-01-06 Camas Incorporated Compositions against bacterial toxins
EP4074395B1 (en) 2011-08-10 2024-01-24 Hemanext Inc. Integrated leukocyte, oxygen and/or co2 depletion, and plasma separation filter device
EP3967143B1 (en) 2013-02-28 2025-05-21 Hemanext Inc. Gas addition device for blood treatment and corresponding method
CN107530377B (zh) 2015-03-10 2021-09-03 新健康科学股份有限公司 氧减少一次性套件、装置及其使用方法
IL285359B2 (en) 2015-04-23 2024-01-01 Hemanext Inc Anaerobic blood storage containers
CN114748503B (zh) 2015-05-18 2025-09-30 希玛奈克斯特股份有限公司 储存全血的方法及其组合物
CN119454953A (zh) 2016-05-27 2025-02-18 希玛奈克斯特股份有限公司 厌氧血液储存和病原体失活方法
US11260119B2 (en) 2018-08-24 2022-03-01 Pfizer Inc. Escherichia coli compositions and methods thereof
US12138302B2 (en) 2020-10-27 2024-11-12 Pfizer Inc. Escherichia coli compositions and methods thereof
US12357681B2 (en) 2020-12-23 2025-07-15 Pfizer Inc. E. coli FimH mutants and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58135819A (ja) * 1982-02-09 1983-08-12 Nisshin Flour Milling Co Ltd 鶏の大腸菌症の予防法
US4772464A (en) * 1985-08-01 1988-09-20 Miles Laboratories, Inc. Protective antibodies to serotypic determinants of flagellar antigens
US4702911A (en) 1985-09-27 1987-10-27 Immunomed Corporation Preparation of bacterium pili subunits and vaccines containing pili subunits
DE3787820T2 (de) * 1986-03-11 1994-04-28 Shionogi & Co Für Flagellin kodierende DNS und dieses enthaltender Vektor.

Also Published As

Publication number Publication date
IL95175A (en) 1994-05-30
EP0413378A1 (en) 1991-02-20
ES2070266T3 (es) 1995-06-01
JPH03184996A (ja) 1991-08-12
GR3015782T3 (en) 1995-07-31
DE69016129D1 (de) 1995-03-02
KR910004209A (ko) 1991-03-28
NZ234933A (en) 1992-06-25
DK0413378T3 (da) 1995-05-15
IL95175A0 (en) 1991-06-10
JP3031561B2 (ja) 2000-04-10
HU211827A9 (en) 1995-12-28
CN1062605C (zh) 2001-02-28
KR0177510B1 (ko) 1999-03-20
AU6109990A (en) 1991-02-21
DE69016129T2 (de) 1995-05-24
CA2022420A1 (en) 1991-02-19
ZA906100B (en) 1991-05-29
TW204353B (OSRAM) 1993-04-21
HU905053D0 (en) 1991-01-28
HUT59612A (en) 1992-06-29
EP0413378B1 (en) 1995-01-18
CA2022420C (en) 2000-03-28
HU210965B (en) 1995-09-28
CN1049523A (zh) 1991-02-27
US5750115A (en) 1998-05-12

Similar Documents

Publication Publication Date Title
AU635062B2 (en) Escherichia coli vaccine
Verstreate et al. Outer membrane proteins of Brucella abortus: isolation and characterization
Luo et al. Cloning and characterization of the major outer membrane protein gene (ompH) of Pasteurella multocida X-73
Beachey et al. Purification and properties of M protein extracted from group A streptococci with pepsin: covalent structure of the amino terminal region of type 24 M antigen
Frasch et al. An outer membrane protein of Neisseria meningitidis group B responsible for serotype specificity
EP0453024B1 (en) Actinobacillus pleuropneumoniae subunit vaccine
DE69110997T2 (de) Haemophilus Paragallinarum-Impfstoffe.
NO175735B (no) Fremgangsmåte ved fremstilling av Pasteurella-vaksine
JP4081140B2 (ja) 非耐熱性エンテロトキシンとコレラトキシンｂサブユニットの雑種分子
US5593679A (en) Poultry vaccine against E. coli air sac inflammation and septicaemia
AU2003204738B2 (en) Vaccines Containing Recombinant Pilin Against Neisseria Gonorrhoeae or Neisseria Meningitidis
Groschup et al. Characterization of a protective protein antigen of Erysipelothrix rhusiopathiae
Tagawa et al. Purification and partial characterization of the major outer membrane protein of Haemophilus somnus
Guzmán-Brambila et al. LKTA and PlpE small fragments fusion protein protect against Mannheimia haemolytica challenge
Rimler Partial purification of cross-protection factor (s) from Pasteurella multocida
CA2516661C (en) M. haemolytica outer membrane protein plpe as a vaccine or vaccine component against shipping fever
Woods et al. Purification and serological characterization of a type-specific antigen of Streptococcus equisimilis
Mahasreshti OmpA family protein of Pasteurella haemolytica: purification, partial characterization and potential immunologic significance
Conceição et al. Protection against Lethal Leptospirosis
AU2004200152A1 (en) Vaccines Containing Recombinant Pilin Against Neisseria Gonorrhoeae or Neisseria Meningitidis